Voruciclib is an orally active and selective CDK inhibitor with Ki values ranging from 0.626 nM to 9.1 nM. It effectively inhibits CDK9, the transcriptional regulator of MCL-1, and suppresses MCL-1 expression in various diffuse large B-cell lymphoma (DLBCL) models [706].
会员登录.getTime()%>){kind=logo}
购物车()
成功收藏产品